About Peplexicon
Peplexicon is an independent research software project building a clearer public evidence layer for consumer peptides, therapeutic peptides, and the products and claims that surround them.
Consumer interest in peptides is growing faster than the information infrastructure around them. Ingredient names, brand names, regulatory status, early research, clinical outcomes, and social-media claims are routinely collapsed into one story. Peplexicon keeps those categories separate and makes the path back to the evidence visible.
Every finding links to the exact passage it rests on and the official source it came from. We label what kind of evidence it is (a phase 3 trial, an animal study, an FDA list or recall) and when it was published. When an AI answer is written, each sentence is checked against its sources and the check is shown. When the evidence is missing, thin, or conflicting, we say so rather than fill the gap.
Peplexicon is an educational research reference and evidence-navigation system. It is not a clinic, pharmacy, drug manufacturer, prescriber, or substitute for medical care. We do not sell peptides, recommend individualized treatment, or treat popularity as proof.
Every claim resolves to an exact quote, its source, the study type or official record, the population, and its limitations.
Missing, conflicting, or indirect evidence belongs in the result—not in fine print.
New research can strengthen, narrow, or overturn an interpretation without erasing its history.